- Home
- TRST vs ORIC Comparison
TRST vs ORIC Comparison
Compare TRST & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRST | ORIC |
|---|---|---|
| Founded | 1902 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 782.5M | 1.2B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TRST | ORIC |
|---|---|---|
| Price | $42.58 | $12.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 113.6K | ★ 1.4M |
| Earning Date | 04-22-2026 | 05-18-2026 |
| Dividend Yield | ★ 3.45% | N/A |
| EPS Growth | ★ 26.46 | 19.67 |
| EPS | ★ 3.25 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.27 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.18 | $3.90 |
| 52 Week High | $48.45 | $14.93 |
Technical Indicators
Market Signals| Indicator | TRST | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 39.31 | 49.51 |
| Support Level | $42.03 | $11.37 |
| Resistance Level | $46.89 | $12.12 |
| Average True Range (ATR) | 1.34 | 0.84 |
| MACD | -0.18 | -0.21 |
| Stochastic Oscillator | 16.25 | 35.24 |
Price Performance
Historical ComparisonAbout TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.